NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Closes
- Jul 5, 2029 (in 968 days)
Similar opportunities open now
- NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses May 2029
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses Nov 10, 2026
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses May 2029
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Apr 2029
- NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Jul 2029Up to $500K
Classification and identifiers
- Solicitation number
- PAR-27-064
- Assistance listing (CFDA)
- 93.855
Amount
Amount not listed here. Check the official program.
Who can apply
Small businesses and Nonprofits can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this opportunity
This notice of funding opportunity (NOFO) encourages applications for implementation of investigator-initiated, milestone driven clinical trials that need enhanced oversight, and as applicable, include mechanistic studies. Mechanistic work in clinical trials may be of great value because it promotes the understanding of human diseases and the development of future therapeutic modalities. Support is available for clinical trials up to 5 years, as well as for extended clinical trials of 6- or 7-years.Investigators are encouraged to visit this NIH website for additional information about the overall mission and research areas of NIAID.Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation Cooperative Agreement (U01) application. In accordance with NIH standard pee...